Kristen Ries, Matthew E. Levison, Donald Kaye
Abstract
Against more than 90% of 200 bacterial strains tested in vitro, the inhibitory concentration of gentamicin and tobramycin was 3.1 mug/ml and that of BB-K 8, a new semisynthetic aminoglycoside derivative of kanamycin, was 6.3 mug/ml.
OpenAlex reports 31 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Against more than 90% of 200 bacterial strains tested in vitro, the inhibitory concentration of gentamicin and tobramycin was 3.1 mug/ml and that of BB-K 8, a new semisynthetic aminoglycoside derivative of kanamycin, was 6.3 mug/ml.
Key concepts: Tobramycin, Aminoglycoside, Kanamycin, Gentamicin, In vitro, Microbiology, Chemistry, Antibacterial agent